Medicale Corp. (MCLE) Common Equity (2020 - 2025)

Medicale (MCLE) has reported Common Equity for 6 consecutive years, with -$145376.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Common Equity fell 25.74% year-over-year to -$145376.0; the trailing twelve-month figure through Dec 2025 stood at -$145376.0 (down 25.74% YoY), and the FY2025 full-year result was -$140086.0, down 41.6% from the prior year.
• Common Equity eased to -$145376.0 in Q4 2025 per MCLE's latest filing, from -$140086.0 in the prior quarter.
• Across five years, Common Equity topped out at $5108.0 in Q1 2021 and bottomed at -$145376.0 in Q4 2025.
• Historically, Common Equity has averaged -$61248.9 across 5 years, with a median of -$47747.0 in 2022.
• The widest YoY moves for Common Equity: up 56.23% in 2022, down 2135.62% in 2022.
• Over 5 years, Common Equity stood at -$27051.0 in 2021, then soared by 56.23% to -$11841.0 in 2022, then sank by 406.94% to -$60027.0 in 2023, then slumped by 92.6% to -$115613.0 in 2024, then retreated by 25.74% to -$145376.0 in 2025.
• According to Business Quant data, Common Equity over the past three periods registered -$145376.0, -$140086.0, and -$129416.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.